Expertise in
12
conditions

Pierre Voisine

Ottawa, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
12
conditions
Ottawa, ON, CA 

Overview

Pierre Voisine practices practicing medicine in Ottawa, Canada.

Mr. Voisine is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Mediastinitis, Aortic Regurgitation, Heart Bypass Surgery, and Aortic Valve Replacement.

He is actively involved in clinical research, co-authoring 132 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

Ottawa, ON K1Y4W7, Canada
Other Locations
Quebec, QC G1V4G5, Canada
Canada
Laval, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Enrollment Status: Recruiting
Publish Date: January 20, 2026
Intervention Type: Drug
Study Drugs: Antiplatelet-only strategy, Anticoagulant+Background antiplatelet therapy
Study Phase: Phase 3
Long-Term Follow-Up For Participants Of: Evaluation Of Outcomes Following Mitral Valve Repair/Replacement In SMR and Surgical Interventions For MMR Trials
Long-Term Follow-Up For Participants Of: Evaluation Of Outcomes Following Mitral Valve Repair/Replacement In SMR and Surgical Interventions For MMR Trials
Enrollment Status: Active_not_recruiting
Publish Date: July 16, 2025
Intervention Type: Other
Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: the ROMA Trial
Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: the ROMA Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 23, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support
A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support
Enrollment Status: Completed
Publish Date: February 06, 2025
Intervention Type: Procedure, Device
Study Phase: Not Applicable
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug
Study Phase: Phase 3
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
Enrollment Status: Completed
Publish Date: June 18, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant
Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant
Enrollment Status: Completed
Publish Date: March 06, 2024
Intervention Type: Diagnostic test, Device
Study Phase: Not Applicable
Prospective, Multi-center, Randomized, Active-control, Non-inferiority Study Comparing Fibrinogen Concentrate With Cryoprecipitate for the Treatment of Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients
Prospective, Multi-center, Randomized, Active-control, Non-inferiority Study Comparing Fibrinogen Concentrate With Cryoprecipitate for the Treatment of Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients
Enrollment Status: Completed
Publish Date: May 14, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

132 Total Publications

Time to Assess the Role of Quality Control in CABG: The SMARTFLOW Trial Program.
Time to Assess the Role of Quality Control in CABG: The SMARTFLOW Trial Program.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: November 21, 2025

Frequently Asked Questions about Pierre Voisine

Is Pierre Voisine a top-rated expert for Heart Bypass Surgery?

MediFind is an objective health platform that identifies experts based on real-world data. Pierre Voisine is classified as an Elite expert for Heart Bypass Surgery, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pierre Voisine participate in research or clinical trials?

Yes. Pierre Voisine has published 132 articles and abstracts on conditions like Heart Bypass Surgery. You can view a list of Pierre Voisine's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Voisine's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile